Adagene
NASDAQ: ADAGFounded 2012 · Incorporated in Cayman Islands · 82 employees on LinkedIn · 4 known investors
Adagene is a clinical-stage immunotherapy company that uses computational biology and artificial intelligence to discover and design therapeutic antibodies for cancer treatment. The company's platform generates novel antibodies aimed at improving safety and efficacy in precision-guided antibody-drug conjugates and other therapeutic approaches.
Investors · 4
Competitors · 5
by search overlap
enGene38 shared keywordsenGene is a genetic medicine company developing drug therapies across oncology, urology, and other therapeutic areas, with a focus on patient outcomes.
Enzene Biosciences Ltd22 shared keywordsEnzene Biosciences is a biologics company focused on the development and manufacturing of biopharmaceuticals. It is a subsidiary of Alkem Laboratories and offers advanced manufacturing processes as a strategic partner for biologic products.
Antengene19 shared keywordsAntengene is a biopharmaceutical company that develops therapies for cancer, with a pipeline focused on hematologic malignancies and solid tumors including Claudin 18.2, CD73, PD-L1/4-1BB bispecific, and CD24-targeting candidates. It is listed on the Hong Kong Stock Exchange and works with global partners on oncology drug development.
Origene19 shared keywordsOriGene supplies research reagents including primary antibodies for flow cytometry, transfection kits (EZ-LNP and ProteanFect), RNAi gene silencing tools, and control solutions for life science laboratories. Its products serve researchers in molecular and cell biology.
Clementia14 shared keywordsIpsen is a biopharmaceutical group that publishes financial, legal, and non-financial reporting for shareholders, investors, and the public through documents such as its Universal Registration Document. The page is the investor reports and accounts section of the company's corporate site.
Companies competing with Adagene for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Adagene do?
- Adagene is a clinical-stage immunotherapy company that uses computational biology and artificial intelligence to discover and design therapeutic antibodies for cancer treatment. The company's platform generates novel antibodies aimed at improving safety and efficacy in precision-guided antibody-drug conjugates and other therapeutic approaches.
- Who are Adagene's investors?
- Adagene's investors include Eight Roads Ventures, F-Prime Capital, Toba Capital, General Atlantic.